MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--DNAnexus, Inc., the leader in biomedical informatics and data management, today announced the appointment of Scott Gibson as Chief Financial Officer. In this role, Gibson will lead finance, legal, human resources, and administration.
“Scott’s diverse background and skill set have helped him grow successful technology businesses over his 30-year career,” said Richard Daly, Chief Executive Officer of DNAnexus. “His recent experience in scaling a SaaS business model coupled with his proficiency overseeing financial planning and analysis will be of great value to DNAnexus as we continue on a strong growth trajectory.”
Gibson has held CFO roles at both public and private firms that cover a broad swath of the tech industry. Prior to joining DNAnexus, Gibson served as CFO at Conviva, a leading data analytics software platform firm in the media space. Previously, he was CFO at several semiconductor, semiconductor equipment, and networking companies. Gibson received his Bachelor of Science in industrial engineering from Iowa State University and his Master of Business Administration from the Stephen M. Ross School of Business at the University of Michigan.
“DNAnexus’ reputation as a leader and innovator in the field of biomedical informatics is well known in the life sciences technology sector,” said Gibson. “I look forward to joining a strong management team and helping drive growth and build the DNAnexus brand.”
DNAnexus, the leader in biomedical informatics and data management, has created the global network for genomics and other biomedical data, operating in 33 countries across North America, South America, Europe, Asia, Australia, and Africa. The secure, scalable, and collaborative DNAnexus Platform helps thousands of researchers across a spectrum of industries – biopharmaceutical, bioagricultural, sequencing services, clinical diagnostics, government, and research consortia – accelerate their genomics programs. For more information on DNAnexus, please visit www.dnanexus.com or follow the company @DNAnexus.